Cognitive functioning, depression, and HIV medication adherence in India: A randomized pilot trial

Ryan Cook, Drenna Waldrop-Valverde, Aman Sharma, Szonja Vamos, Biraaj Mahajan, Stephen M Weiss, Mahendra Kumar, Ritu Nehra, Deborah Jones

Research output: Contribution to journalArticle

Abstract

Objective: India is home to the third-largest number of people living with HIV in the world, and no-cost antiretroviral therapy (ART) has been available across the country since 2004. However, rates of adherence to ART are often subpar in India, and interventions to increase adherence are warranted. Cognitive impairment and depression have been associated with ART non-adherence, and may also limit the impact of behavioral interventions designed to improve adherence. Studies have not evaluated the impact of cognitive impairment and depression on response to adherence interventions in India. Methods: Individuals new to ART (≤12 months prescribed) were recruited from a public hospital in Chandigarh, India. Participants (N = 80) were randomized to either a group medication adherence intervention (MAI) or an enhanced standard of care (ESOC) condition. The MAI consisted of three monthly gender-concordant group cognitive-behavioral sessions addressing HIV and ART, adherence, and HIV-related coping and social support. Participants were assessed at baseline for depression and cognitive functioning, and assessed monthly for adherence by pill count. Results: Adherence among participants receiving the MAI improved by about one day’s dose over the course of the study, and no improvement was noted among those in the ESOC. Additionally, high rates of cognitive impairment (57%) and depression (25%) were identified among participants. There was no evidence that cognitive impairment moderated response to the intervention. However, while non-depressed participants benefitted from the intervention, depressed participants failed to show the same improvement. Conclusions: Results of this pilot study suggest that group behavioral interventions can be an effective strategy to promote ART adherence in this population, even among those demonstrating cognitive impairment. However, because of the negative impact of depression on adherence, future studies should continue to develop strategies to identify and treat it among people living with HIV in India.

Original languageEnglish (US)
Pages (from-to)640-652
Number of pages13
JournalHealth Psychology and Behavioral Medicine
Volume2
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

Medication Adherence
India
medication
HIV
Depression
Standard of Care
Therapeutics
Public Hospitals
Social Support
Group
Cognitive Dysfunction
Costs and Cost Analysis
social support
coping
Population
gender

Keywords

  • Adherence
  • Cognitive functioning
  • Depression
  • HIV
  • India

ASJC Scopus subject areas

  • Psychology(all)
  • Behavioral Neuroscience
  • Health(social science)

Cite this

Cognitive functioning, depression, and HIV medication adherence in India : A randomized pilot trial. / Cook, Ryan; Waldrop-Valverde, Drenna; Sharma, Aman; Vamos, Szonja; Mahajan, Biraaj; Weiss, Stephen M; Kumar, Mahendra; Nehra, Ritu; Jones, Deborah.

In: Health Psychology and Behavioral Medicine, Vol. 2, No. 1, 01.01.2013, p. 640-652.

Research output: Contribution to journalArticle

Cook, Ryan ; Waldrop-Valverde, Drenna ; Sharma, Aman ; Vamos, Szonja ; Mahajan, Biraaj ; Weiss, Stephen M ; Kumar, Mahendra ; Nehra, Ritu ; Jones, Deborah. / Cognitive functioning, depression, and HIV medication adherence in India : A randomized pilot trial. In: Health Psychology and Behavioral Medicine. 2013 ; Vol. 2, No. 1. pp. 640-652.
@article{5a5a9ab67066430ca06c711c8e438989,
title = "Cognitive functioning, depression, and HIV medication adherence in India: A randomized pilot trial",
abstract = "Objective: India is home to the third-largest number of people living with HIV in the world, and no-cost antiretroviral therapy (ART) has been available across the country since 2004. However, rates of adherence to ART are often subpar in India, and interventions to increase adherence are warranted. Cognitive impairment and depression have been associated with ART non-adherence, and may also limit the impact of behavioral interventions designed to improve adherence. Studies have not evaluated the impact of cognitive impairment and depression on response to adherence interventions in India. Methods: Individuals new to ART (≤12 months prescribed) were recruited from a public hospital in Chandigarh, India. Participants (N = 80) were randomized to either a group medication adherence intervention (MAI) or an enhanced standard of care (ESOC) condition. The MAI consisted of three monthly gender-concordant group cognitive-behavioral sessions addressing HIV and ART, adherence, and HIV-related coping and social support. Participants were assessed at baseline for depression and cognitive functioning, and assessed monthly for adherence by pill count. Results: Adherence among participants receiving the MAI improved by about one day’s dose over the course of the study, and no improvement was noted among those in the ESOC. Additionally, high rates of cognitive impairment (57{\%}) and depression (25{\%}) were identified among participants. There was no evidence that cognitive impairment moderated response to the intervention. However, while non-depressed participants benefitted from the intervention, depressed participants failed to show the same improvement. Conclusions: Results of this pilot study suggest that group behavioral interventions can be an effective strategy to promote ART adherence in this population, even among those demonstrating cognitive impairment. However, because of the negative impact of depression on adherence, future studies should continue to develop strategies to identify and treat it among people living with HIV in India.",
keywords = "Adherence, Cognitive functioning, Depression, HIV, India",
author = "Ryan Cook and Drenna Waldrop-Valverde and Aman Sharma and Szonja Vamos and Biraaj Mahajan and Weiss, {Stephen M} and Mahendra Kumar and Ritu Nehra and Deborah Jones",
year = "2013",
month = "1",
day = "1",
doi = "10.1080/21642850.2014.913487",
language = "English (US)",
volume = "2",
pages = "640--652",
journal = "Health Psychology and Behavioral Medicine",
issn = "2164-2850",
publisher = "Taylor and Francis Ltd.",
number = "1",

}

TY - JOUR

T1 - Cognitive functioning, depression, and HIV medication adherence in India

T2 - A randomized pilot trial

AU - Cook, Ryan

AU - Waldrop-Valverde, Drenna

AU - Sharma, Aman

AU - Vamos, Szonja

AU - Mahajan, Biraaj

AU - Weiss, Stephen M

AU - Kumar, Mahendra

AU - Nehra, Ritu

AU - Jones, Deborah

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Objective: India is home to the third-largest number of people living with HIV in the world, and no-cost antiretroviral therapy (ART) has been available across the country since 2004. However, rates of adherence to ART are often subpar in India, and interventions to increase adherence are warranted. Cognitive impairment and depression have been associated with ART non-adherence, and may also limit the impact of behavioral interventions designed to improve adherence. Studies have not evaluated the impact of cognitive impairment and depression on response to adherence interventions in India. Methods: Individuals new to ART (≤12 months prescribed) were recruited from a public hospital in Chandigarh, India. Participants (N = 80) were randomized to either a group medication adherence intervention (MAI) or an enhanced standard of care (ESOC) condition. The MAI consisted of three monthly gender-concordant group cognitive-behavioral sessions addressing HIV and ART, adherence, and HIV-related coping and social support. Participants were assessed at baseline for depression and cognitive functioning, and assessed monthly for adherence by pill count. Results: Adherence among participants receiving the MAI improved by about one day’s dose over the course of the study, and no improvement was noted among those in the ESOC. Additionally, high rates of cognitive impairment (57%) and depression (25%) were identified among participants. There was no evidence that cognitive impairment moderated response to the intervention. However, while non-depressed participants benefitted from the intervention, depressed participants failed to show the same improvement. Conclusions: Results of this pilot study suggest that group behavioral interventions can be an effective strategy to promote ART adherence in this population, even among those demonstrating cognitive impairment. However, because of the negative impact of depression on adherence, future studies should continue to develop strategies to identify and treat it among people living with HIV in India.

AB - Objective: India is home to the third-largest number of people living with HIV in the world, and no-cost antiretroviral therapy (ART) has been available across the country since 2004. However, rates of adherence to ART are often subpar in India, and interventions to increase adherence are warranted. Cognitive impairment and depression have been associated with ART non-adherence, and may also limit the impact of behavioral interventions designed to improve adherence. Studies have not evaluated the impact of cognitive impairment and depression on response to adherence interventions in India. Methods: Individuals new to ART (≤12 months prescribed) were recruited from a public hospital in Chandigarh, India. Participants (N = 80) were randomized to either a group medication adherence intervention (MAI) or an enhanced standard of care (ESOC) condition. The MAI consisted of three monthly gender-concordant group cognitive-behavioral sessions addressing HIV and ART, adherence, and HIV-related coping and social support. Participants were assessed at baseline for depression and cognitive functioning, and assessed monthly for adherence by pill count. Results: Adherence among participants receiving the MAI improved by about one day’s dose over the course of the study, and no improvement was noted among those in the ESOC. Additionally, high rates of cognitive impairment (57%) and depression (25%) were identified among participants. There was no evidence that cognitive impairment moderated response to the intervention. However, while non-depressed participants benefitted from the intervention, depressed participants failed to show the same improvement. Conclusions: Results of this pilot study suggest that group behavioral interventions can be an effective strategy to promote ART adherence in this population, even among those demonstrating cognitive impairment. However, because of the negative impact of depression on adherence, future studies should continue to develop strategies to identify and treat it among people living with HIV in India.

KW - Adherence

KW - Cognitive functioning

KW - Depression

KW - HIV

KW - India

UR - http://www.scopus.com/inward/record.url?scp=85006780719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006780719&partnerID=8YFLogxK

U2 - 10.1080/21642850.2014.913487

DO - 10.1080/21642850.2014.913487

M3 - Article

VL - 2

SP - 640

EP - 652

JO - Health Psychology and Behavioral Medicine

JF - Health Psychology and Behavioral Medicine

SN - 2164-2850

IS - 1

ER -